The UK Technology Strategy Board (TSB) is to provide new investment of up to £2 million for collaborative feasibility studies to stimulate innovation in different areas of ‘enabling technologies’, including biosciences.
The TSB will provide part-funding to conduct early-stage projects with a ‘significant level of technical risk’ that involves ‘some level of uncertainty about how the proposed technical approach will work in practice’; business partners are expected to provide the rest of the funding. Projects must be led by a ‘small or micro’ company with at least one business or research partner, and cost between £50-£150k.
In the biosciences, appropriate types of studies are said to include:
- commercial application of sequencing technologies focusing on genomics
- integration and exploitation of phenotyping technologies
- integration of 'omics technologies eg. metabolomic, proteomic, genomic and phenomic data collection and interpretation capabilities
- biological imaging systems, biosensors, probes/ markers, diagnostic platforms.
- novel biological production systems
- bioinformatics approaches to data organisation, filtering and interpretation
The competition will open on 6th May and run until 25 June.